Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 63.60M | £ 41.80M | £ 87.00M | £ 60.80M | £ 109.60M |
Total Assets | £ 1.36B | £ 1.28B | £ 1.13B | £ 1.08B | £ 1.12B |
Total Debt | £ 414.00M | £ 391.20M | £ 324.80M | £ 344.50M | £ 381.20M |
Net Debt | £ 350.40M | £ 349.40M | £ 237.80M | £ 283.70M | £ 271.60M |
Total Liabilities | £ 793.10M | £ 727.10M | £ 656.70M | £ 663.80M | £ 711.40M |
Stockholders Equity | £ 564.60M | £ 551.00M | £ 470.40M | £ 417.80M | £ 408.40M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |